The particle number size distribution (PNSD) and hygroscopicity on alpine sites can directly reflect the interaction between aerosol and cloud in the free troposphere, and narrow the errors caused by extrapolation from the ground observation. In this study, PNSD and cloud condensation nuclei (CCN) concentration (N CCN ) were observed at the summit of Mt. Hua from December 16, 2020, to January 23, 2021. The result showed that the modes and hygroscopicity parameters (κ) of aerosols were significantly affected by the height and direction of the originated air masses. The particle in nucleation mode from new particle formation erupted frequently in 13:00-18:00 local time due to the intense photochemistry and had a potential contribution to CCN through the process of the growth with the ratio of 0.83 nm•h −1 , which was affected by air masses, meteorological conditions, and gaseous pollutants. Subsequently, the hygroscopicity κ varied from 0.22 to 0.13 with the supersaturation from 0.2% to 1.0% as more components that were difficult to dissolve or had low hygroscopicity. The comprehensive analysis of PNSD and hygroscopicity showed that smaller k from two-parameter power model corresponded to particles with higher hygroscopicity or larger diameter, while larger k matched to the hydrophobic or ultrafine particles. In addition, the interactions between aerosol and cloud were estimated more accurately and the uncertainty of indirect effect was shrunk. Overall, we provided insights into PNSD and hygroscopicity of alpine aerosol particles by direct observation on Mt. Hua, which may be important to other elevated regions as well.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.